| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |